Menu
Back to Journals » Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (677)
- Volume 18, 2025 (12)
- Volume 17, 2024 (44)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
- 677 records -
Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
Chen Q, Zhang W, Zha L
Pharmacogenomics and Personalized Medicine 2025, 18:153-162
Published Date: 17 June 2025
Associations Between FTO Polymorphisms and Neuroblastoma Risk in Chinese Children
Liu P, Li Y, Li Y, Li L, Cheng J, Li S, Zhang J, Zhou H, Huo Y, Yang Z, He J, Zhang R
Pharmacogenomics and Personalized Medicine 2025, 18:143-151
Published Date: 27 May 2025
Quercetin Inhibits Gastric Cancer Progression via FAM198B/MAPK Pathway Modulation
Deng H, Xiao Q, Xu X, Zhang L, Zhang Y
Pharmacogenomics and Personalized Medicine 2025, 18:115-141
Published Date: 15 May 2025
Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China
Li XP, Wang JL, Lei SX, Chen BY, Ma X, He F, Yue CF, Liu HX, Hu JP, Xiong Q, Ji T, Zhang ZF, Sun Y, Li HW
Pharmacogenomics and Personalized Medicine 2025, 18:105-113
Published Date: 2 May 2025
Clinicopathological and Molecular Features of Primary Inflammatory Myofibroblastic Tumor in Nasal Cavity and Paranasal Sinuses
Zhao Y, Ma D, Wan H, Piao Y
Pharmacogenomics and Personalized Medicine 2025, 18:95-104
Published Date: 28 April 2025
Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screening
Lin P, Liu H, Lou J, Lyu G, Li Y, He P, Fu Y, Zhang R, Zhang Y, Yan T
Pharmacogenomics and Personalized Medicine 2025, 18:85-94
Published Date: 23 April 2025
Association of MiRNA Polymorphisms Involved in the PI3K/ATK/GSK3β Pathway with T2DM in a Chinese Population
Zhou X, Yang M, Yang Y, Xu F, Wang F, Jiao M, Tao W, Li Y
Pharmacogenomics and Personalized Medicine 2025, 18:71-84
Published Date: 14 February 2025
Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review
Katabalo DM, Mwita S, Liwa AC, Kidenya BR, Schroeder K
Pharmacogenomics and Personalized Medicine 2025, 18:55-69
Published Date: 14 February 2025
A Novel Pathogenic Splicing Mutation of OFD1 is Responsible for a Boy with Joubert Syndrome Exhibiting Orofaciodigital Spectrum Anomalies, Polydactyly and Retinitis Pigmentosa
Chen L, Zhao MF, Deng HW, Liao M, Fan LL, Zhong QB, Wang J, Li K, Wu ZH, Yin JY
Pharmacogenomics and Personalized Medicine 2025, 18:47-53
Published Date: 3 February 2025
Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
Luo X, Chen L, Xu J, Li J
Pharmacogenomics and Personalized Medicine 2025, 18:35-46
Published Date: 31 January 2025
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
Borbón A, Briceño JC, Valderrama-Aguirre A
Pharmacogenomics and Personalized Medicine 2025, 18:19-34
Published Date: 30 January 2025
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder
He Y, He Y, Cheng B
Pharmacogenomics and Personalized Medicine 2025, 18:1-18
Published Date: 17 January 2025
PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Du P, Li X, Li D, Ma Y, Ni M, Li Y, Li W, Wang A, Xu X
Pharmacogenomics and Personalized Medicine 2024, 17:611-621
Published Date: 21 December 2024
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward
Ram M, Fraser MR, Vieira dos Santos J, Tasakis R, Islam A, Abo-Donia JU, Parekh S, Lagana A
Pharmacogenomics and Personalized Medicine 2024, 17:573-609
Published Date: 21 December 2024
The Association of PLA2G7 Gene Polymorphisms with Serum Lp-PLA2 Activity and Lipid Profile in Han Chinese Patients with Coronary Heart Disease
Wang Y, Shi Y, Wu Z, Gao J, Wang J, Li L, Wan Y, Lang A M, Zhang J, Wang H, Hou Y
Pharmacogenomics and Personalized Medicine 2024, 17:563-572
Published Date: 21 December 2024
Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with Dyslipidemia
Chen C, Tian Y, Jia F, Feng M, Zhang G, Li Q, Zhang Y, Sun N, Hu S, Ji Z
Pharmacogenomics and Personalized Medicine 2024, 17:551-561
Published Date: 20 December 2024
CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
Dong YM, Bao GQ
Pharmacogenomics and Personalized Medicine 2024, 17:535-550
Published Date: 17 December 2024
Prognostic Value and Immunological Role of POP7 in Clear Cell Renal Cell Carcinoma
Lou N, Meng X, Yu T, Li W, Lv X, Han W, Xiao W, Shi Y
Pharmacogenomics and Personalized Medicine 2024, 17:521-534
Published Date: 26 November 2024
Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
Tang Y, He Y, Wu L
Pharmacogenomics and Personalized Medicine 2024, 17:511-520
Published Date: 20 November 2024
Immune Microenvironment Alterations and Identification of Key Diagnostic Biomarkers in Chronic Kidney Disease Using Integrated Bioinformatics and Machine Learning
Shi J, Xu A, Huang L, Liu S, Wu B, Zhang Z
Pharmacogenomics and Personalized Medicine 2024, 17:497-510
Published Date: 19 November 2024
Genetic Diversity Landscape in African Population: A Review of Implications for Personalized and Precision Medicine
Sibomana O
Pharmacogenomics and Personalized Medicine 2024, 17:487-496
Published Date: 11 November 2024
Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension
Jan A, Alanzi AR, Mothana RA, Kaimori JY, Ali SS, Muhammad T, Saeed M, Akbar R, Khan M
Pharmacogenomics and Personalized Medicine 2024, 17:473-486
Published Date: 29 October 2024
Bioinformatics-Based Identification of Key Prognostic Genes in Neuroblastoma with a Focus on Immune Cell Infiltration and Diagnostic Potential of VGF
Guo Q, Xiao Y, Chu J, Sun Y, Li S, Zhang S
Pharmacogenomics and Personalized Medicine 2024, 17:453-472
Published Date: 10 October 2024
Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients
Liu S, Li J, Zhang Z, Meng D, Wang K
Pharmacogenomics and Personalized Medicine 2024, 17:443-452
Published Date: 30 September 2024
A Case Report of Hemiplegic Migraine with Mutation in the ATP1A2 Gene
Guan DM, Shan YZ, Zhao HT, Meng Y, Yan ZR, Zhang HL
Pharmacogenomics and Personalized Medicine 2024, 17:437-442
Published Date: 20 September 2024
TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma
Chen C, Zou Y, Zheng X, Hu T, Ni J, Kan D, Yin Z, Ye L, Liu B
Pharmacogenomics and Personalized Medicine 2024, 17:423-435
Published Date: 3 September 2024
Acyl-CoA Thioesterase 8 (ACOT8) is a Poor Prognostic Biomarker in Breast Cancer
Wang Z, Wang H
Pharmacogenomics and Personalized Medicine 2024, 17:403-421
Published Date: 22 August 2024
Mitochondrial Diabetes May Not Be the Only Phenotypic Presentation of the m.5826A>G mtDNA Variant [Letter]
Finsterer J
Pharmacogenomics and Personalized Medicine 2024, 17:401-402
Published Date: 25 July 2024
M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics
Huang F, Wang Y, Shao Y, Zhang R, Li M, Liu L, Zhao Q
Pharmacogenomics and Personalized Medicine 2024, 17:383-399
Published Date: 11 July 2024
Identification and Validation of Glycosylation-Related Genes in Obesity and MASH: Insights from Human Liver Samples and a High-Fat Diet Mouse Model
Yu W, Chen J, Jin S, Fan X, Cai X
Pharmacogenomics and Personalized Medicine 2024, 17:363-381
Published Date: 5 July 2024
The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review
Getahun KA, Angaw DA, Asres MS, Kahaliw W, Petros Z, Abay SM, Yimer G, Berhane N
Pharmacogenomics and Personalized Medicine 2024, 17:347-361
Published Date: 1 July 2024
Influence of Long Non-Coding RNAs on Human Oocyte Development
Wang L, Li B, Cheng D
Pharmacogenomics and Personalized Medicine 2024, 17:337-345
Published Date: 1 July 2024
Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
Zhou Q, Liu Y, Gao Y, Quan L, Wang L, Wang H
Pharmacogenomics and Personalized Medicine 2024, 17:319-336
Published Date: 25 June 2024
Preliminary Study on Clinical Characteristics and Pathogenesis of IQSEC2 Mutations Patients
Ren Y, Luo X, Tong H, Wang S, Yan J, Lin L, Chen Y
Pharmacogenomics and Personalized Medicine 2024, 17:289-318
Published Date: 29 May 2024
The Correlation of Centromere Protein Q with Diagnosis and Prognosis in Hepatocellular Carcinoma
He K, Xie MY, Gao XJ, Wang H, Li JD
Pharmacogenomics and Personalized Medicine 2024, 17:271-288
Published Date: 27 May 2024
An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
Zhou Y, Yang Z, Zeng H
Pharmacogenomics and Personalized Medicine 2024, 17:251-270
Published Date: 23 May 2024
16S rRNA Gene Sequencing of Gut Microbiota in Rheumatoid Arthritis Treated with 99Tc-MDP
Huang Z, Chen C, Tan L, Ling Y, Ma W, Zhang J
Pharmacogenomics and Personalized Medicine 2024, 17:237-249
Published Date: 23 May 2024
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Teng JM, Qin S, Lu D, Gu Y, Tang SJ, Yan Q, Yao J, Zhang C
Pharmacogenomics and Personalized Medicine 2024, 17:225-236
Published Date: 14 May 2024
To Investigate the Influence of Smoking Cessation Intention and Common Downstream Variants of HDAC9 Gene on Large Artery Atherosclerotic Cerebral Infarction
Yu L, Zhao Y
Pharmacogenomics and Personalized Medicine 2024, 17:215-224
Published Date: 13 May 2024
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine
Younis MA, Harashima H
Pharmacogenomics and Personalized Medicine 2024, 17:193-213
Published Date: 7 May 2024
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus
Degaga A, Sirgu S, Huri HZ, Sim MS, Loganadan NK, Kebede T, Tegene B, Engidawork E, Shibeshi W
Pharmacogenomics and Personalized Medicine 2024, 17:183-191
Published Date: 3 May 2024
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024
ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
Deng X, Guo X, Chen X, Zeng X, Guo J, Bai X, Zhang P, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:163-169
Published Date: 20 April 2024
Identification of a Novel Mitochondrial tRNA Mutation in Chinese Family with Type 2 Diabetes Mellitus
Li X, Shang J, Li S, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:149-161
Published Date: 17 April 2024
Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD
Xu H, Zhang H, Sun S, Zhang J, Huo J, Zhou C
Pharmacogenomics and Personalized Medicine 2024, 17:133-148
Published Date: 16 April 2024
Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype
Zhang D, Bai J
Pharmacogenomics and Personalized Medicine 2024, 17:125-131
Published Date: 16 April 2024
Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development
Zhao Z, Xing N, Guo H, Li J, Sun G
Pharmacogenomics and Personalized Medicine 2024, 17:105-123
Published Date: 11 April 2024
Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
Guo S, Bai W, Cui F, Chen X, Fang X, Shen H, Gu X
Pharmacogenomics and Personalized Medicine 2024, 17:91-103
Published Date: 3 April 2024
The Association Between Mitochondrial tRNAGlu Variants and Hearing Loss: A Case-Control Study
Yu X, Li S, Guo Q, Leng J, Ding Y
Pharmacogenomics and Personalized Medicine 2024, 17:77-89
Published Date: 28 March 2024
Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways
Lin H, Ni L, Phuong C, Hong JC
Pharmacogenomics and Personalized Medicine 2024, 17:65-76
Published Date: 13 February 2024